Diverse, high-quality test set for the validation of protein-ligand docking performance

被引:493
作者
Hartshorn, Michael J. [1 ]
Verdonk, Marcel L. [1 ]
Chessari, Gianni [1 ]
Brewerton, Suzanne C. [1 ]
Mooij, Wijnand T. M. [1 ]
Mortenson, Paul N. [1 ]
Murray, Christopher W. [1 ]
机构
[1] Astex Therapeut Ltd, Cambridge CB4 0QA, England
关键词
D O I
10.1021/jm061277y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A procedure for analyzing and classifying publicly available crystal structures has been developed. It has been used to identify high-resolution protein-ligand complexes that can be assessed by reconstructing the electron density for the ligand using the deposited structure factors. The complexes have been clustered according to the protein sequences, and clusters have been discarded if they do not represent proteins thought to be of direct interest to the pharmaceutical or agrochemical industry. Rules have been used to exclude complexes containing non-drug-like ligands. One complex from each cluster has been selected where a structure of sufficient quality was available. The final Astex diverse set contains 85 diverse, relevant protein-ligand complexes, which have been prepared in a format suitable for docking and are to be made freely available to the entire research community (http://www.ccdc.cam.ac.uk). The performance of the docking program GOLD against the new set is assessed using a variety of protocols. Relatively unbiased protocols give success rates of approximately 80% for redocking into native structures, but it is possible to get success rates of over 90% with some protocols.
引用
收藏
页码:726 / 741
页数:16
相关论文
共 137 条
[1]  
Accelrys Inc, 2005, INSIGHTII
[2]   The Cambridge Structural Database: a quarter of a million crystal structures and rising [J].
Allen, FH .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 2002, 58 (3 PART 1) :380-388
[3]   The structural basis of blebbistatin inhibition and specificity for myosin II [J].
Allingham, JS ;
Smith, R ;
Rayment, I .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2005, 12 (04) :378-379
[4]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[5]   BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design [J].
Babu, YS ;
Chand, P ;
Bantia, S ;
Kotian, P ;
Dehghani, A ;
El-Kattan, Y ;
Lin, TH ;
Hutchison, TL ;
Elliott, AJ ;
Parker, CD ;
Ananth, SL ;
Horn, LL ;
Laver, GW ;
Montgomery, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (19) :3482-3486
[6]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[7]   Structural characterization of the GSK-3β active site using selective and non-selective ATP-mimetic inhibitors [J].
Bertrand, JA ;
Thieffine, S ;
Vulpetti, A ;
Cristiani, C ;
Valsasina, B ;
Knapp, S ;
Kalisz, HM ;
Flocco, M .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 333 (02) :393-407
[8]   Dynamic roles of arginine residues 82 and 92 of Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase:: Crystallographic studies [J].
Blaszczyk, J ;
Li, Y ;
Shi, GB ;
Yan, HG ;
Ji, XH .
BIOCHEMISTRY, 2003, 42 (06) :1573-1580
[9]   Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition [J].
Bledsoe, RK ;
Montana, VG ;
Stanley, TB ;
Delves, CJ ;
Apolito, CJ ;
McKee, DD ;
Consler, TG ;
Parks, DJ ;
Stewart, EL ;
Willson, TM ;
Lambert, MH ;
Moore, JT ;
Pearce, KH ;
Xu, HE .
CELL, 2002, 110 (01) :93-105
[10]   Structural basis for antagonism and resistance of bicalutamide in prostate cancer [J].
Bohl, CE ;
Gao, WQ ;
Miller, DD ;
Bell, CE ;
Dalton, JT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (17) :6201-6206